| Medical and Health Sciences | Lifetime | 484 | US 263 | 99.98 |
| Psychiatry and Mental health | Lifetime | 40 | US 23 | 99.88 |
| Clinical Neurology | Lifetime | 70 | US 30 | 99.77 |
| Medical Physiology | Lifetime | 181 | US 104 | 99.72 |
| Cognitive Neuroscience | Lifetime | 190 | US 98 | 99.62 |
| Neuroscience of Neurology | Lifetime | 206 | US 88 | 98.37 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 999 | US 531 | 97.17 |
| Management Information Systems | Lifetime | 824 | US 320 | 94.63 |
| Psychiatry and Mental health | 2021-2025 | 105 | US 37 | 98.17 |
| Clinical Neurology | 2021-2025 | 150 | US 56 | 96.39 |
| Cognitive Neuroscience | 2021-2025 | 277 | US 113 | 94.98 |
| Medical Physiology | 2021-2025 | 454 | US 165 | 93.49 |
| Alzheimer's disease research and treatments | Lifetime | 22 | US 16 | 99.95 |
| Amyotrophic Lateral Sclerosis Research | Lifetime | 5 | US 4 | 99.85 |
| Dementia and Cognitive Impairment Research | Lifetime | 15 | US 10 | 99.94 |
| Parkinson's Disease Mechanisms and Treatments | Lifetime | 93 | US 36 | 99.63 |
| Functional Brain Connectivity Studies | Lifetime | 172 | US 85 | 99.52 |
| Neurobiology of Language and Bilingualism | Lifetime | 75 | US 33 | 98.95 |
| Neuroprotection in Stroke and Neurodegeneration | Lifetime | 123 | US 45 | 98.57 |
| Spatial Neglect and Hemispheric Dysfunction | Lifetime | 30 | US 15 | 98.54 |
| Neurological diseases and metabolism | Lifetime | 88 | US 33 | 98.80 |
| Neurological Disease Mechanisms and Treatments | Lifetime | 232 | US 91 | 98.05 |
| Prion Diseases and Protein Misfolding | Lifetime | 114 | US 50 | 97.90 |
| Memory and Neural Mechanisms | Lifetime | 350 | US 198 | 98.07 |
| Advanced Neuroimaging Techniques and Applications | Lifetime | 574 | US 265 | 97.79 |
| Psychosomatic Disorders and Their Treatments | Lifetime | 431 | US 156 | 96.99 |
| Cholinesterase and Neurodegenerative Diseases | Lifetime | 546 | US 209 | 96.21 |
| Fungal and yeast genetics research | Lifetime | 598 | US 270 | 96.27 |
| Neurological and metabolic disorders | Lifetime | 274 | US 117 | 94.82 |
| Fungal Biology and Applications | Lifetime | 924 | US 156 | 95.45 |
| Genetic Neurodegenerative Diseases | Lifetime | 869 | US 325 | 95.73 |
| Cerebrovascular and genetic disorders | Lifetime | 125 | US 32 | 95.09 |
| S100 Proteins and Annexins | Lifetime | 660 | US 286 | 94.47 |
| Mental Health and Psychiatry | Lifetime | 655 | US 269 | 95.31 |
| Ethics in medical practice | Lifetime | 689 | US 356 | 93.38 |
| Action Observation and Synchronization | Lifetime | 971 | US 274 | 89.71 |
| 14-3-3 protein interactions | Lifetime | 463 | US 182 | 85.20 |
| Hallucinations in medical conditions | Lifetime | 99 | US 21 | 83.96 |
| Alcoholism and Thiamine Deficiency | Lifetime | 933 | US 398 | 84.16 |
| Advanced Queuing Theory Analysis | Lifetime | 935 | US 345 | 86.36 |
| Neurology and Historical Studies | Lifetime | 695 | US 298 | 80.50 |
| Ginkgo biloba and Cashew Applications | Lifetime | 993 | US 222 | 74.37 |
| Dementia and Cognitive Impairment Research | 2021-2025 | 134 | US 62 | 98.65 |
| Alzheimer's disease research and treatments | 2021-2025 | 117 | US 53 | 98.69 |
| Amyotrophic Lateral Sclerosis Research | 2021-2025 | 76 | US 21 | 96.76 |
| Parkinson's Disease Mechanisms and Treatments | 2021-2025 | 605 | US 130 | 93.53 |
| Aging, Elder Care, and Social Issues | 2021-2025 | 108 | US 9 | 82.74 |
| Neurobiology of Language and Bilingualism | 2021-2025 | 351 | US 129 | 86.97 |
| Epilepsy research and treatment | 2021-2025 | 900 | US 284 | 87.31 |
| Neurological diseases and metabolism | 2021-2025 | 796 | US 154 | 61.34 |
| Spatial Neglect and Hemispheric Dysfunction | 2021-2025 | 199 | US 26 | 60.84 |
| Prion Diseases and Protein Misfolding | 2021-2025 | 623 | US 184 | 58.61 |
| Interpreting and Communication in Healthcare | 2021-2025 | 779 | US 274 | 46.61 |
| Cerebrovascular and genetic disorders | 2021-2025 | 646 | US 106 | 41.39 |